The Indian pharmaceutical industry, long hailed as the 'pharmacy of the world,' is undergoing a significant transformation. While it continues to be a major contributor to India's economic growth, the sector is rapidly shifting its focus from generic drugs to more advanced areas such as MedTech and biosimilars. MedTech focuses...
Assessing India’s Impact on Global Healthcare
India has emerged as a significant player in the global healthcare landscape, significantly shaping the accessibility and affordability of essential medicines. As the world's leading supplier of generic drugs, India's pharmaceutical industry services hundreds of millions of global citizens in need. By quantity, India accounts for 20% of global generic...
New Delhi-Based Panacea Biotec Wins $127 Million Contract
Vaccine maker Panacea Biotec received a long-term supply contract worth over $127 million from UNICEF and the Pan American Health Organization (PAHO) for supply of its WHO pre-qualified fully liquid pentavalent vaccine, Easyfive-TT (DTwP-HepB-Hib). This vaccine protects children against five deadly diseases: Diphtheria, Tetanus, Pertussis, Hepatitis B and invasive infections...
Germany Approves Bharat Biotech’s COVAXIN for Travel
German Ambassador to India and Bhutan, Walter J Lindner, announced that the government of Germany recognized WHO-listed Bharat Biotech's Covid vaccine, COVAXIN, for travel to the country starting June 1. In November last year the World Health Organization issued an emergency use listing for Covaxin, adding to a growing portfolio...
Harsh Vardhan: Minister for Health and Family Welfare, Science and Technology, Earth Sciences
Born in New Delhi on December 13, 1954, Harsh Vardhan is a physician with a degree from GSVM Medical College in Kanpur. As junior Minister for Health in 1994 he implemented the pilot project of the Pulse Polio Program, which involved the immunization of one million children up to the...
India's Bharat Biotech To Start Phase-1 Trials of Zika Vaccine
After completing pre-clinical studies on its new Zika vaccine candidate Zikavac, Hyderabad, India-based Bharat Biotech announced that the company is now seeking the approval of the government to begin Phase-1 trials where the inactivated vaccine candidate will be tested on 100 people, reports BioSpectrum. India has no known cases of...